Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Andrew M. Albrecht Author

Min.Li@uth.tmc.edu

Subjects of specialization
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker

Affiliation
The Vivian L. Smith Department of Neurosurgery, The University of Texas Medical School at Houston, Houston, Texas, USA

Biography

Andrew M. Albrecht was working in the The Vivian L. Smith Department of Neurosurgery, The University of Texas Medical School at Houston, Houston, Texas, USA. Doctor has more than 40 publications. Doctor's current research area related to clinical oncology.

Publications

Editorial Open Access

Combinational Treatment for Pancreatic Cancer: Where Are We Standing?

Author(s):

Andrew M. Albrecht, Jingxuan Yang and Min Li

Combinational Treatment for Pancreatic Cancer: Where Are We Standing?

Pancreatic cancer has one of the highest mortality rates of all cancers, with an incredibly poor prognosis, aggressive metastasis, and limited choice of therapy. Of the estimated 43,920 new cases of pancreatic cancer diagnosed in 2012, only 5.8% are likely to survive beyond 5 years. Currently, surgical resection is the only effective treatment for this devastating disease. However, only around 15% of the patient population is eligible forview more»

DOI: 10.4172/2324-9110.1000e103

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP